Molina Healthcare, Inc. (NYSE:MOH) Director Ronna Romney sold 375 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $121.97, for a total transaction of $45,738.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Shares of NYSE:MOH traded up $4.76 during trading on Friday, reaching $126.18. The company had a trading volume of 1,025,811 shares, compared to its average volume of 726,956. Molina Healthcare, Inc. has a twelve month low of $105.28 and a twelve month high of $159.00. The firm has a market capitalization of $7.55 billion, a PE ratio of 11.39, a price-to-earnings-growth ratio of 1.11 and a beta of 1.12. The firm’s fifty day moving average is $116.55 and its 200 day moving average is $130.14. The company has a debt-to-equity ratio of 0.80, a quick ratio of 1.78 and a current ratio of 1.78.
Molina Healthcare (NYSE:MOH) last released its earnings results on Tuesday, October 29th. The company reported $2.80 EPS for the quarter, beating the consensus estimate of $2.70 by $0.10. Molina Healthcare had a net margin of 4.47% and a return on equity of 49.14%. The business had revenue of $4.24 billion during the quarter, compared to analyst estimates of $4.15 billion. During the same period in the prior year, the business earned $2.97 earnings per share. The business’s quarterly revenue was down 9.7% on a year-over-year basis. Equities analysts predict that Molina Healthcare, Inc. will post 11.52 earnings per share for the current fiscal year.
MOH has been the subject of a number of research analyst reports. ValuEngine lowered shares of Molina Healthcare from a “hold” rating to a “sell” rating in a research note on Wednesday, October 30th. Deutsche Bank initiated coverage on shares of Molina Healthcare in a research note on Thursday, September 12th. They issued a “buy” rating and a $145.00 price target for the company. Morgan Stanley reduced their price target on shares of Molina Healthcare from $172.00 to $158.00 and set an “overweight” rating for the company in a research note on Thursday, October 31st. Stephens set a $150.00 price target on shares of Molina Healthcare and gave the stock a “hold” rating in a research note on Wednesday, August 7th. Finally, Jefferies Financial Group lowered shares of Molina Healthcare from a “buy” rating to a “hold” rating and reduced their price target for the stock from $133.00 to $120.00 in a research note on Wednesday, October 30th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $154.33.
About Molina Healthcare
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
See Also: How Buying a Call Option Works
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.